138 related articles for article (PubMed ID: 30844798)
1. Chenodeoxycholic Acid Releases Proinflammatory Cytokines from Small Intestinal Epithelial Cells Through the Farnesoid X Receptor.
Horikawa T; Oshima T; Li M; Kitayama Y; Eda H; Nakamura K; Tamura A; Ogawa T; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Tomita T; Fukui H; Watari J; Miwa H
Digestion; 2019; 100(4):286-294. PubMed ID: 30844798
[TBL] [Abstract][Full Text] [Related]
2. Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages.
Cao S; Meng X; Li Y; Sun L; Jiang L; Xuan H; Chen X
Front Immunol; 2021; 12():632864. PubMed ID: 33968024
[TBL] [Abstract][Full Text] [Related]
3. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
Gadaleta RM; van Erpecum KJ; Oldenburg B; Willemsen EC; Renooij W; Murzilli S; Klomp LW; Siersema PD; Schipper ME; Danese S; Penna G; Laverny G; Adorini L; Moschetta A; van Mil SW
Gut; 2011 Apr; 60(4):463-72. PubMed ID: 21242261
[TBL] [Abstract][Full Text] [Related]
5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
6. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
[TBL] [Abstract][Full Text] [Related]
7. Chenodeoxycholic Acid Reduces Hypoxia Inducible Factor-1α Protein and Its Target Genes.
Moon Y; Choi SM; Chang S; Park B; Lee S; Lee MO; Choi HS; Park H
PLoS One; 2015; 10(6):e0130911. PubMed ID: 26098428
[TBL] [Abstract][Full Text] [Related]
8. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone.
Wang S; Lai K; Moy FJ; Bhat A; Hartman HB; Evans MJ
Endocrinology; 2006 Sep; 147(9):4025-33. PubMed ID: 16675527
[TBL] [Abstract][Full Text] [Related]
9. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
[TBL] [Abstract][Full Text] [Related]
10. Morphologic Damage of Rat Alveolar Epithelial Type II Cells Induced by Bile Acids Could Be Ameliorated by Farnesoid X Receptor Inhibitor Z-Guggulsterone In Vitro.
Wang J; Huang Y; Hou X; Wu W; Nie L; Tian Y; Lu Y; Yin Y
Biomed Res Int; 2016; 2016():9283204. PubMed ID: 27340672
[TBL] [Abstract][Full Text] [Related]
11. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene.
Owsley E; Chiang JY
Biochem Biophys Res Commun; 2003 Apr; 304(1):191-5. PubMed ID: 12705905
[TBL] [Abstract][Full Text] [Related]
12. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
Bennet SM; Polster A; Törnblom H; Isaksson S; Capronnier S; Tessier A; Le Nevé B; Simrén M; Öhman L
Am J Gastroenterol; 2016 Aug; 111(8):1165-76. PubMed ID: 27272011
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2.
Smyth JS; Truong JK; Rao A; Lin R; Foulke-Abel J; Adorini L; Donowitz M; Dawson PA; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G446-G452. PubMed ID: 37697930
[TBL] [Abstract][Full Text] [Related]
14. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
Campana G; Pasini P; Roda A; Spampinato S
Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.
van Schaik FD; Gadaleta RM; Schaap FG; van Mil SW; Siersema PD; Oldenburg B; van Erpecum KJ
PLoS One; 2012; 7(11):e49706. PubMed ID: 23189156
[TBL] [Abstract][Full Text] [Related]
17. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.
Neimark E; Chen F; Li X; Shneider BL
Hepatology; 2004 Jul; 40(1):149-56. PubMed ID: 15239098
[TBL] [Abstract][Full Text] [Related]
18. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
[TBL] [Abstract][Full Text] [Related]
19. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
[TBL] [Abstract][Full Text] [Related]
20. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.
Li WT; Luo QQ; Wang B; Chen X; Yan XJ; Qiu HY; Chen SL
FASEB J; 2019 Feb; 33(2):2435-2450. PubMed ID: 30260705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
